Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.
To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with tacrolimus
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Wu Y et al. | Increased macrophage activation inhibited by tacrolimus in the kidney of diabetic rats. | 2014 | Nephron Exp. Nephrol. | pmid:25376933 |
Catalano G et al. | Everolimus-based immunosuppression in a case of ABO-incompatible liver transplantation with calcineurin inhibitor-related posterior occipital syndrome. | 2014 | Transpl. Int. | pmid:24606320 |
Zhang Y et al. | Genome-wide identification and analysis of FK506-binding protein gene family in peach (Prunus persica). | 2014 | Gene | pmid:24342662 |
Shin BH et al. | Regulation of anti-HLA antibody-dependent natural killer cell activation by immunosuppressive agents. | 2014 | Transplantation | pmid:24342979 |
Saito K et al. | Severe diffuse duodenitis successfully treated with intravenous tacrolimus after colectomy for ulcerative colitis. | 2014 | Intern. Med. | pmid:25366006 |
Siddiqui A et al. | Chemometric methods for the quantification of crystalline tacrolimus in solid dispersion by powder X-ray diffractrometry. | 2014 | J Pharm Sci | pmid:24585357 |
Shivaswamy V et al. | Tacrolimus and sirolimus have distinct effects on insulin signaling in male and female rats. | 2014 | Transl Res | pmid:24361102 |
Uesugi S et al. | Calcineurin inhibitors suppress the high-temperature stress sensitivity of the yeast ubiquitin ligase Rsp5 mutant: a new method of screening for calcineurin inhibitors. | 2014 | FEMS Yeast Res. | pmid:25035868 |
Labrador J et al. | Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus. | 2014 | Bone Marrow Transplant. | pmid:24566710 |
Goldberg NR et al. | Success with single-agent immunosuppression for multifocal choroidopathies. | 2014 | Am. J. Ophthalmol. | pmid:25194229 |
Liu Y et al. | Role of retrograde trafficking in stress response, host cell interactions, and virulence of Candida albicans. | 2014 | Eukaryotic Cell | pmid:24363364 |
Wei TQ et al. | Sandwich assay for tacrolimus using 2 antitacrolimus antibodies. | 2014 | Clin. Chem. | pmid:24381229 |
Oellerich M et al. | Use of graft-derived cell-free DNA as an organ integrity biomarker to reexamine effective tacrolimus trough concentrations after liver transplantation. | 2014 | Ther Drug Monit | pmid:24452066 |
Suarez-Kurtz G et al. | Pharmacogenomic implications of population admixture: Brazil as a model case. | 2014 | Pharmacogenomics | pmid:24444410 |
Kurzawski M et al. | CYP3A5 and CYP3A4, but not ABCB1 polymorphisms affect tacrolimus dose-adjusted trough concentrations in kidney transplant recipients. | 2014 | Pharmacogenomics | pmid:24444408 |
Ducroux E et al. | Hidradenitis suppurativa after renal transplantation: complete remission after switching from oral cyclosporine to oral tacrolimus. | 2014 | J. Am. Acad. Dermatol. | pmid:25437996 |
Khorrami A et al. | Tacrolimus ameliorates functional disturbances and oxidative stress in isoproterenol-induced myocardial infarction. | 2014 | Daru | pmid:25312839 |
Xue F et al. | CYP3A5 genotypes affect tacrolimus pharmacokinetics and infectious complications in Chinese pediatric liver transplant patients. | 2014 | Pediatr Transplant | pmid:24438215 |
Chen YK et al. | Personalized tacrolimus dose requirement by CYP3A5 but not ABCB1 or ACE genotyping in both recipient and donor after pediatric liver transplantation. | 2014 | PLoS ONE | pmid:25310192 |
Mai HL et al. | IL-7 receptor blockade following T cell depletion promotes long-term allograft survival. | 2014 | J. Clin. Invest. | pmid:24569454 |
Tokuoka H et al. | Nurr1 expression is regulated by voltage-dependent calcium channels and calcineurin in cultured hippocampal neurons. | 2014 | Neurosci. Lett. | pmid:24291696 |
Steinebrunner N et al. | Pharmacodynamic monitoring of nuclear factor of activated T cell-regulated gene expression in liver allograft recipients on immunosuppressive therapy with calcineurin inhibitors in the course of time and correlation with acute rejection episodes--a prospective study. | 2014 | Ann. Transplant. | pmid:24457606 |
Hancock WW | Effects of histone deacetylase inhibitors on alloresponses. | 2014 | Lancet Oncol. | pmid:24295573 |
Müller GG et al. | Topical tacrolimus 0.03% as sole therapy in vernal keratoconjunctivitis: a randomized double-masked study. | 2014 | Eye Contact Lens | pmid:24418865 |
Hesselink DA et al. | The role of pharmacogenetics in the disposition of and response to tacrolimus in solid organ transplantation. | 2014 | Clin Pharmacokinet | pmid:24249597 |
Fuchs U et al. | Clinical outcome in heart transplant recipients receiving everolimus in combination with dosage reduction of the calcineurin inhibitor cyclosporine A or tacrolimus. | 2014 | Transpl. Immunol. | pmid:24932812 |
Zhu X et al. | Pilot study using tacrolimus rather than cyclosporine plus antithymocyte globulin as an immunosuppressive therapy regimen option for severe aplastic anemia in adults. | 2014 | Blood Cells Mol. Dis. | pmid:24931461 |
Han N et al. | Population pharmacokinetic-pharmacogenetic model of tacrolimus in the early period after kidney transplantation. | 2014 | Basic Clin. Pharmacol. Toxicol. | pmid:24238261 |
Taguchi K et al. | False tacrolimus concentrations measured by antibody-conjugated magnetic immunoassay in liver transplant patient: 2 case reports and literature review. | 2014 | Exp Clin Transplant | pmid:24206050 |
Rangel EB | Tacrolimus in pancreas transplant: a focus on toxicity, diabetogenic effect and drug-drug interactions. | 2014 | Expert Opin Drug Metab Toxicol | pmid:25255841 |
Trotter JF and Lizardo-Sanchez L | Everolimus in liver transplantation. | 2014 | Curr Opin Organ Transplant | pmid:25254569 |
Doligalski CT et al. | Sublingual administration of tacrolimus: current trends and available evidence. | 2014 | Pharmacotherapy | pmid:25251980 |
RodrÃguez-Serrano M et al. | Does the calcineurin inhibitor have influence on cytomegalovirus infection in heart transplantation? | 2014 | Clin Transplant | pmid:24325305 |
Souza MC et al. | Tacrolimus-loaded PLGA implants: in vivo release and ocular toxicity. | 2014 | Curr. Eye Res. | pmid:24325382 |
Sharp WW et al. | Dynamin-related protein 1 (Drp1)-mediated diastolic dysfunction in myocardial ischemia-reperfusion injury: therapeutic benefits of Drp1 inhibition to reduce mitochondrial fission. | 2014 | FASEB J. | pmid:24076965 |
Talreja N et al. | Successful desensitization to agalsidase beta after anaphylaxis. | 2014 | Ann. Allergy Asthma Immunol. | pmid:24331397 |
Sæves I et al. | Tacrolimus exposure and mycophenolate pharmacokinetics and pharmacodynamics early after liver transplantation. | 2014 | Ther Drug Monit | pmid:24081206 |
Burroughs LM et al. | Treosulfan-based conditioning and hematopoietic cell transplantation for nonmalignant diseases: a prospective multicenter trial. | 2014 | Biol. Blood Marrow Transplant. | pmid:25196857 |
Musuamba FT et al. | Population pharmacokinetic analysis of tacrolimus early after pediatric liver transplantation. | 2014 | Ther Drug Monit | pmid:24081207 |
Ghanem RC et al. | Tacrolimus for the treatment of subepithelial infiltrates resistant to topical steroids after adenoviral keratoconjunctivitis. | 2014 | Cornea | pmid:25188789 |
Ricciardelli I et al. | Towards gene therapy for EBV-associated posttransplant lymphoma with genetically modified EBV-specific cytotoxic T cells. | 2014 | Blood | pmid:25185261 |
Mujtaba MA et al. | Conversion from tacrolimus to belatacept to prevent the progression of chronic kidney disease in pancreas transplantation: case report of two patients. | 2014 | Am. J. Transplant. | pmid:25179306 |
Mabe S et al. | Detecting protein-protein interactions based on kinase-mediated growth induction of mammalian cells. | 2014 | Sci Rep | pmid:25135216 |
Sol Fustiñana M et al. | Protein degradation by ubiquitin-proteasome system in formation and labilization of contextual conditioning memory. | 2014 | Learn. Mem. | pmid:25135196 |
Takeuchi T et al. | Tacrolimus-induced left ventricular apical hypertrophy in a patient with post-allogeneic hematopoietic stem cell transplantation. | 2014 | Int. J. Cardiol. | pmid:25131917 |
Huang H et al. | Effect and mechanism of tacrolimus on melanogenesis on A375 human melanoma cells. | 2014 | Chin. Med. J. | pmid:25131236 |
Gürkan A et al. | Alpha 2 integrin gene (ITGA2) polymorphism in renal transplant recipients with and without drug induced gingival overgrowth. | 2014 | Arch. Oral Biol. | pmid:24581850 |
Spasovski G and Masin-Spasovska J | How to improve the survival of the kidney transplant - is it only the pharmaceutical management? | 2014 | Expert Opin Pharmacother | pmid:24617949 |
Choi SW et al. | Vorinostat plus tacrolimus and mycophenolate to prevent graft-versus-host disease after related-donor reduced-intensity conditioning allogeneic haemopoietic stem-cell transplantation: a phase 1/2 trial. | 2014 | Lancet Oncol. | pmid:24295572 |
Kim JS et al. | Effects of FK-506 and CTLA4--Ig on nerve allografts in mice. | 2014 | J Plast Reconstr Aesthet Surg | pmid:24120418 |
Görzer I et al. | Plasma DNA levels of Torque teno virus and immunosuppression after lung transplantation. | 2014 | J. Heart Lung Transplant. | pmid:24559947 |
Wang B et al. | Multifaceted interaction of the traditional Chinese medicinal herb Schisandra chinensis with cytochrome P450-mediated drug metabolism in rats. | 2014 | J Ethnopharmacol | pmid:25091466 |
Bao J and Liang H | Tacrolimus-induced permanent asymptomatic pontine myelinolysis after liver transplantation. | 2014 | Intern. Med. | pmid:25088893 |
Purani JM and Purani HJ | Treatment of geographic tongue with topical tacrolimus. | 2014 | BMJ Case Rep | pmid:25085945 |
Kornblit B et al. | A randomized phase II trial of tacrolimus, mycophenolate mofetil and sirolimus after non-myeloablative unrelated donor transplantation. | 2014 | Haematologica | pmid:25085357 |
Yuan C et al. | A simple and robust LC-MS/MS method for measuring sirolimus and everolimus in whole blood. | 2014 | Bioanalysis | pmid:25077621 |
Kyriakou A et al. | Therapeutic efficacy of topical calcineurin inhibitors in plasma cell balanitis: case series and review of the literature. | 2014 | Dermatology (Basel) | pmid:24434685 |
Thapa RK and Yoo BK | Evaluation of the effect of tacrolimus-loaded liquid crystalline nanoparticles on psoriasis-like skin inflammation. | 2014 | J Dermatolog Treat | pmid:23210668 |
Viecelli A et al. | Diagnostic and management dilemma of a pancreas-kidney transplant recipient with aplastic anaemia. | 2014 | BMJ Case Rep | pmid:25257886 |
Yamazoe K et al. | Efficacy and safety of systemic tacrolimus in high-risk penetrating keratoplasty after graft failure with systemic cyclosporine. | 2014 | Cornea | pmid:25255133 |
Zwiech R | [The early C4d urinary excretion and long-term kidney graft survival in patients treated with tacrolimus and mycophenolate mophetil]. | 2014 | Pol. Merkur. Lekarski | pmid:24779215 |
Segarra-Medrano A et al. | Evolution of antibody titre against the M-type phospholipase A2 receptor and clinical response in idiopathic membranous nephropathy patients treated with tacrolimus. | 2014 | Nefrologia | pmid:25036063 |
Boschetti G et al. | Tacrolimus induction followed by maintenance monotherapy is useful in selected patients with moderate-to-severe ulcerative colitis refractory to prior treatment. | 2014 | Dig Liver Dis | pmid:25023007 |
John K et al. | Role of dendritic cells in the context of acute cellular rejection: comparison between tacrolimus- or cyclosporine A-treated heart transplanted recipients. | 2014 | Cytometry B Clin Cytom | pmid:24668729 |
Okamoto T et al. | Clinically mild encephalitis/encephalopathy with a reversible splenial lesion associated with febrile urinary tract infection. | 2014 | Eur. J. Pediatr. | pmid:24221606 |
Personett HA et al. | Impact of molecular adsorbent recirculating system therapy on tacrolimus elimination: a case report. | 2014 | Transplant. Proc. | pmid:25017243 |
Steinebrunner N et al. | Reduced residual gene expression of nuclear factor of activated T cells-regulated genes correlates with the risk of cytomegalovirus infection after liver transplantation. | 2014 | Transpl Infect Dis | pmid:24666466 |
Nomura H et al. | A patient with lupus miliaris disseminatus faciei treated successfully with a combination of oral metronidazole and topical tacrolimus. | 2014 | J. Dermatol. | pmid:24931738 |
Rahman Z et al. | Near-infrared and fourier transform infrared chemometric methods for the quantification of crystalline tacrolimus from sustained-release amorphous solid dispersion. | 2014 | J Pharm Sci | pmid:24931728 |
Kim SH et al. | Expression, purification and characterization of soluble recombinant peptidyl-prolyl cis/trans isomerase from Vibrio anguillarum. | 2014 | Protein Expr. Purif. | pmid:24931498 |
Gibbs BF et al. | Highly specific targeting of human leukocytes using gold nanoparticle-based biologically active conjugates. | 2014 | J Biomed Nanotechnol | pmid:24804546 |
Enderby CY et al. | Tacrolimus dosage requirements in lung transplant recipients receiving antifungal prophylaxis with voriconazole followed by itraconazole: a preliminary prospective study. | 2014 | Clin Transplant | pmid:24931421 |
Richards KR et al. | Tacrolimus trough level at discharge predicts acute rejection in moderately sensitized renal transplant recipients. | 2014 | Transplantation | pmid:24784360 |
Cutler C et al. | Tacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT. | 2014 | Blood | pmid:24982504 |
Liu Z et al. | Tacrolimus-based versus cyclosporine-based immunosuppression in hepatitis C virus-infected patients after liver transplantation: a meta-analysis and systematic review. | 2014 | PLoS ONE | pmid:25198195 |
Tran D et al. | Conversion from twice-daily to once-daily extended-release tacrolimus in renal transplant recipients: 2-year results and review of the literature. | 2014 | Exp Clin Transplant | pmid:24844288 |
Feng S et al. | A rapidly reversible chemical dimerizer system to study lipid signaling in living cells. | 2014 | Angew. Chem. Int. Ed. Engl. | pmid:24841150 |
Rotter D et al. | Calcineurin and its regulator, RCAN1, confer time-of-day changes in susceptibility of the heart to ischemia/reperfusion. | 2014 | J. Mol. Cell. Cardiol. | pmid:24838101 |
Kahvecioglu S et al. | Effects of calcineurin inhibitors on paraoxonase and arylesterase activity after a kidney transplant. | 2014 | Exp Clin Transplant | pmid:24447269 |
Marin-Casino M et al. | Significant tacrolimus and dronedarone interaction in a kidney transplant recipient. | 2014 | Transplantation | pmid:25243519 |
Kalkan G et al. | An alternative treatment model: the combination therapy of narrow band ultraviolet B phototherapy and tacrolimus ointment 0.1% in biphasic amyloidosis. | 2014 | J Pak Med Assoc | pmid:25272550 |
Fazal MA et al. | Dyslipidaemia among renal transplant recipients: cyclosporine versus tacrolimus. | 2014 | J Pak Med Assoc | pmid:25272531 |
Doren EL and Aya-ay ML | Pyoderma gangrenosum following breast reduction: treatment with topical tacrolimus and steroids. | 2014 | Aesthet Surg J | pmid:24448967 |
Taimur S et al. | Donor T-cell chimerism and early post-transplant cytomegalovirus viremia in patients treated with myeloablative allogeneic hematopoietic stem cell transplant. | 2014 | Transpl Infect Dis | pmid:24251680 |
Lin YH and Pratt MR | A dual small-molecule rheostat for precise control of protein concentration in Mammalian cells. | 2014 | Chembiochem | pmid:24615791 |
Hashi S et al. | Assessment of four methodologies (microparticle enzyme immunoassay, chemiluminescent enzyme immunoassay, affinity column-mediated immunoassay, and flow injection assay-tandem mass spectrometry) for measuring tacrolimus blood concentration in Japanese liver transplant recipients. | 2014 | Transplant. Proc. | pmid:24767342 |
Uemoto S et al. | Safety and efficacy of once-daily modified-release tacrolimus in liver transplant recipients: a multicenter postmarketing surveillance in Japan. | 2014 | Transplant. Proc. | pmid:24767340 |
Muduma G et al. | A UK analysis of the cost of switching renal transplant patients from an immediate-release to a prolonged-release formulation of tacrolimus based on differences in trough concentration variability. | 2014 | J Med Econ | pmid:24754700 |
Bloch J et al. | Donor ABCB1 genetic polymorphisms influence epithelial-to-mesenchyme transition in tacrolimus-treated kidney recipients. | 2014 | Pharmacogenomics | pmid:25521359 |
Zhang X et al. | Profiling of drug binding proteins by monolithic affinity chromatography in combination with liquid chromatography-tandem mass spectrometry. | 2014 | J Chromatogr A | pmid:25064533 |
Borda B et al. | Side effects of the calcineurin inhibitor, such as new-onset diabetes after kidney transplantation. | 2014 | Acta Physiol Hung | pmid:25183511 |
Hodzic E et al. | Posterior reversible encephalopathy syndrome (PRES) as a complication of immunosuppressive therapy in renal transplantation in children. | 2014 | Med Arh | pmid:25195358 |
Chen Y et al. | Comparison of long-term impact of immunosuppressants at therapeutic doses on hepatic function and histological changes in unilateral nephrectomized rats. | 2014 | Exp. Toxicol. Pathol. | pmid:25081300 |
Elens L et al. | Clinical implementation of pharmacogenetics in kidney transplantation: calcineurin inhibitors in the starting blocks. | 2014 | Br J Clin Pharmacol | pmid:24118098 |
DÃaz-GarcÃa C et al. | Pregnancy after allogeneic uterus transplantation in the rat: perinatal outcome and growth trajectory. | 2014 | Fertil. Steril. | pmid:25439799 |
Ibrahim O et al. | The role of infliximab in the treatment of superficial granulomatous pyoderma of the head and neck. | 2014 | J. Am. Acad. Dermatol. | pmid:25438004 |
Kraaij MD et al. | Human monocytes produce interferon-gamma upon stimulation with LPS. | 2014 | Cytokine | pmid:24680476 |
Sawamoto K et al. | Mechanisms of lower maintenance dose of tacrolimus in obese patients. | 2014 | Drug Metab. Pharmacokinet. | pmid:24670405 |
Xie M et al. | Brucellosis infection in an adult liver transplant recipient. | 2014 | Transpl Infect Dis | pmid:24666385 |
Takazono T et al. | Paradoxical response to disseminated non-tuberculosis mycobacteriosis treatment in a patient receiving tumor necrosis factor-α inhibitor: a case report. | 2014 | BMC Infect. Dis. | pmid:24576098 |